Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Urologic Oncology|July 23, 2020
Discontinuation of first-line molecular-targeted therapy and prognosis in patients with metastatic renal cell carcinoma: Impact of disease progression vs. adverse eventsRyosuke Ando, Kiyoshi Takahara, Toshiki Ito, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancerKenji Kuroda, Yutaka Horiguchi, Jun Nakashima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 25, 2005
Three-dimensional ultrasonography in evaluation of benign prostatic hyperplasiaKent Kanao, Eiji Kikuchi, Jun Nakashima, et al.
BJU International|January 19, 2016
Plasma fibrinogen level: an independent prognostic factor for disease-free survival and cancer-specific survival in patients with localised renal cell carcinomaJun Obata, Nobuyuki Tanaka, Ryuichi Mizuno, et al.
Cureus|June 13, 2024
Choroidal Metastasis From Papillary Renal Cell Carcinomas: A Case Report and a Review of the LiteratureShinnosuke Hiruta, Go Kaneko, Yu Miyama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 8, 2016
Novel algorithm for management of acute epididymitisHiroshi Hongo, Eiji Kikuchi, Kazuhiro Matsumoto, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 10, 2015
Optimal method for measuring tumor extent in needle biopsy specimens to identify small-volume prostate cancerKeishi Kajikawa, Kent Kanao, Ikuo Kobayashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 19, 2018
Impact of a novel biopsy instrument with a 25-mm side-notch needle on the detection of prostate cancer in transrectal biopsyKent Kanao, Keishi Kajikawa, Ikuo Kobayashi, et al.
IJU Case Reports|May 5, 2022
Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long-term treatment-free survival with pembrolizumab and axitinib in the KEYNOTE-426 phase III trial of pembrolizumab and axitinib versus sunitinibKoshiro Nishimoto, Suguru Shirotake, Yu Miyama, et al.
Urology|February 3, 2007
Interleukin 6 is associated with cachexia in patients with prostate cancerKenji Kuroda, Jun Nakashima, Kent Kanao, et al.
Pageof 8